TAK Sale Disclosure
Duprey Lauren Rusckowski · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$640.28K
Duprey Lauren Rusckowski Chief Transformation Officer
Transaction date
Sep 14, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 2 days later
TAK daily price context
Close on/before transaction
$18.6
Sep 14, 2026
Close before public filing
$18.7
Sep 15, 2026
Return since public filing
+1.12%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- American Depositary Shares
- Quantity / price
- 34,535 shares @ $18.54
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001395064-26-000340
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$640.28K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Takeda Pharmaceutical Co Ltd TAK Current | Sale | Sep 14, 2026 | $640.28K |